of 2035 population
Cardiovascular Disease
Cardiovascular disease remains the largest cause of mortality and healthcare costs, yet most therapies only address risk factors or disease symptoms, rather than improving heart function.
of 2035 population
deaths
Precision Cardiology is Emerging
New genetic and functional insights are enabling precision therapies that can address disease drivers and improve patient heart function
Past
Drugging Risk Factors


Future
Drugging Heart Function

However, so far there is a lack of well-characterized precision drug targets that have been genetically and functionally validated in humans.